 |
The Lancet in conversation withAuthor: The Lancet Group
Jessamy Bagenal, Chloe Wilson, and Callum Davidsoneditors at The Lancetand Gavin Cleaver, The Lancet Groups Audio Producer, in conversation with the journals authors, explore their latest research and its impact on peoples health, healthcare, and health policy. A monthly audio companion to the journal, this podcast covers topics that advance the field of medical research, from exploring treatments to examining drug trials, public health outbreaks to surgical techniques, and more. Language: en Genres: Health & Fitness, Life Sciences, Medicine, Science Contact email: Get it Feed URL: Get it iTunes ID: Get it |
Listen Now...
Presented at ESMO: the HARMONi-6 study on a bispecific antibody therapy for squamous NSCLC
Sunday, 19 October, 2025
Shun Lu joins Ben Abbott of The Lancet to discuss the phase 3 HARMONi-6 trial of ivonescimab plus chemotherapy as first-line treatment in advanced squamous non-small-cell lung cancer, which is being presented at ESMO 2025.Click here to read the full articleContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv
